Tag: ESOC 2025
Brainomix announces multiple study presentations highlighting clinical impact of 360 Stroke...
Brainomix has announced the recent presentation of a series of studies at the European Stroke Organisation Conference (ESOC; 21–23 May, Helsinki, Finland), providing new...
Individualised BP management during thrombectomy shows no benefit over standard approach
The DETERMINE randomised controlled trial (RCT) has found that individualised blood pressure (BP) management during mechanical thrombectomy for patients with anterior large vessel occlusion...
Carotid stenting is a safe and effective EVT adjunct in tandem-lesion...
Findings from a real-world cohort of more than 4,000 patients suggest that adding emergent carotid artery stenting (eCAS) to endovascular therapy (EVT) for anterior-circulation...
Telemedicine-based mobile stroke units prove safe and more resource-efficient than traditional...
Results from the MSU-TELEMED randomised controlled trial—presented at the 11th European Stroke Organisation Conference (ESOC; 21–23 May, Helsinki, Finland)—have demonstrated that telemedicine-based neurologist assessments...
Fresh DISTAL and ESCAPE-MeVO analyses further elucidate stroke thrombectomy’s role in...
Two analyses disclosed for the first time at the 11th European Stroke Organisation Conference (ESOC; 21–23 May, Helsinki, Finland) have shed fresh light on the...
AI-based clinical decision support system reduces new vascular events and mortality...
A large, multicentre, cluster-randomised trial in China—GOLDEN BRIDGE II—has demonstrated that integrating a clinical decision support system (CDSS) into routine acute ischaemic stroke care...
Revalesio announces post-hoc analysis suggesting greater benefit with RNS60 in early...
Revalesio has announced data from a post-hoc analysis of its completed Phase 2 RESCUE clinical trial showing that ischaemic stroke patients treated with 1mL/kg/h...
‘Bridging’ thrombolysis with tenecteplase produces improved stroke outcomes versus thrombectomy alone
The BRIDGE-TNK randomised clinical trial has shown better outcomes in stroke patients receiving thrombectomy plus ‘bridging treatment’ with the intravenous thrombolytic drug tenecteplase as...
Route 92 announces presentation of SUMMIT MAX results and gains new...
Today, Route 92 Medical has announced positive results from its SUMMIT MAX randomised controlled trial (RCT) comparing the efficacy and safety of the HiPoint...
Less frequent stroke monitoring is safe, effective and can free up...
Halving the frequency with which vital signs and neurological function are checked in low-risk patients after treatment for acute ischaemic stroke does not compromise...
